Jasper Therapeutics Announces 1-for-30 Reverse Stock Split
Jasper Therapeutics (JSPR) has officially announced a 1-for-30 reverse stock split of its common stock. This corporate action is intended to consolidate the company's outstanding shares, effectively increasing the price per share by a factor of 30. The reverse split is scheduled to take effect at 12:01 a.m. ET on Friday, November 6, 2026. Following this adjustment, shares are expected to begin trading on a split-adjusted basis during the market open on that same day.
Tickers: $JSPR